Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-05-21

FDA Approved: ALBUTEROL — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved the original application for albuterol from Amneal Pharmaceuticals NY LLC, enabling a generic albuterol inhalation product to enter the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albuterol (albuterol)

Snippet

ORIG AP for ALBUTEROL (ALBUTEROL)